Entacapone in restless legs syndrome

Movement Disorders

Volumn 17, Issue 2, 2002, Pages 421-

  Sharif, Ashfaq A ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENZODIAZEPINE; CARBIDOPA PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; GABAPENTIN; IRON; LEVODOPA; OPIATE; PRAMIPEXOLE; PRAVASTATIN; QUININE; TOLCAPONE; VITAMIN;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG WITHDRAWAL; FEMALE; HUMAN; NAUSEA; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SUSTAINED RELEASE FORMULATION; SYMPTOMATOLOGY;

ANTIPARKINSON AGENTS; CARBIDOPA; CATECHOLS; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEVODOPA; MIDDLE AGED; NEUROLOGIC EXAMINATION; RESTLESS LEGS SYNDROME;

EID: 0036523786     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10080     Document Type: Article

References (4)

1. Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. Boston: Butterworth-Heinemann; 1996.
2. Ondo WG, Vuong KD, Wang Q. Restless Legs Syndrdome in monozygotic twins. Neurology 2000;55:1404-1406.
3. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65.
4. Schapira AHV, Obeso JA, Olanow CW. The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease. Neurology 2000;55(Suppl. 4):S65-S68.